Logo image of MRNA

MODERNA INC (MRNA) Stock Analyst Earnings Estimates

NASDAQ:MRNA - Nasdaq - US60770K1079 - Common Stock - Currency: USD

26.12  -0.49 (-1.84%)

After market: 26.22 +0.1 (+0.38%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
MRNA revenue by date.MRNA revenue by date.
19.263B
4.29%
6.848B
-64.45%
3.236B
-52.75%
2.122B
-34.43%
2.335B
10.04%
2.839B
21.58%
4.459B
57.06%
7.353B
64.90%
10.971B
49.20%
7.835B
-28.58%
8.846B
12.90%
EBITDA
YoY % growth
MRNA ebitda by date.MRNA ebitda by date.
9.768B
-27.79%
-1.418B
-114.52%
-3.261B
-129.97%
-4.018B
-23.21%
-3.067B
23.66%
-1.883B
38.60%
213.18M
111.32%
1.508B
607.38%
2.615B
73.41%
3.703B
41.61%
4.822B
30.22%
EBIT
YoY % growth
MRNA ebit by date.MRNA ebit by date.
9.42B
-29.15%
-2.039B
-121.65%
-3.45B
-69.20%
-4.204B
-21.85%
-3.29B
21.74%
-2.165B
34.21%
-987.602M
54.38%
829.99M
184.04%
3.034B
265.55%
1.851B
-38.99%
2.699B
45.81%
Operating Margin
MRNA operating margin by date.MRNA operating margin by date.
48.90%-29.78%-106.61%-198.10%-140.90%-76.25%-22.15%11.29%27.65%23.62%30.51%
EPS
YoY % growth
MRNA eps by date.MRNA eps by date.
19.96
-29.45%
-12.41
-162.17%
-9.28
25.22%
-10.34
-11.41%
-7.82
24.39%
-5.03
35.61%
-1.55
69.17%
3.27
310.44%
8.11
148.43%
5.31
-34.58%
6.99
31.78%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-2.00
-6,768.08%
-3.02
-3.67%
-2.69
-6.70%
-2.78
-30.57%
-0.94
53.09%
-1.54
48.83%
Revenue
Q2Q % growth
988.43M
-46.92%
754.24M
-21.92%
132.57M
22.75%
111.95M
-21.16%
1.471B
48.82%
1.091B
44.65%
EBITDA
Q2Q % growth
-922.789M
-438.02%
-1.216B
-40.75%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-841.453M
-684.34%
-1.265B
-20.15%
-1.023B
-1.53%
-1.108B
-27.56%
-205.869M
75.53%
-542.184M
57.14%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-2.13
36.04%
-3.030.9029.60%
Q1 2025
Q2Q % growth
-2.52
17.92%
-3.200.6821.22%
Q4 2024
Q2Q % growth
-2.91
-629.09%
-2.74-0.17-6.26%
Q3 2024
Q2Q % growth
0.03
100.31%
-1.951.98101.54%
Q2 2024
Q2Q % growth
-3.33
8.01%
-3.450.123.51%
Q1 2024
Q2Q % growth
-3.07
-1,715.79%
-3.660.5916.04%
Q4 2023
Q2Q % growth
0.55
-84.76%
-0.991.54155.49%
Q3 2023
Q2Q % growth
-9.53
-476.68%
-1.97-7.56-384.77%
Q2 2023
Q2Q % growth
-3.62
-169.08%
-4.120.5012.15%
Q1 2023
Q2Q % growth
0.19
-97.79%
-1.812.00110.52%
Q4 2022
Q2Q % growth
3.61
-68.02%
4.77-1.16-24.31%
Q3 2022
Q2Q % growth
2.53
-67.14%
3.36-0.83-24.66%
Q2 2022
Q2Q % growth
5.24
-18.89%
4.640.6012.94%
Q1 2022
Q2Q % growth
8.58
202.11%
5.323.2661.43%
Q4 2021
Q2Q % growth
11.29
1,736.23%
10.101.1911.80%
Q3 2021
Q2Q % growth
7.70
1,405.08%
9.23-1.53-16.58%
Q2 2021
Q2Q % growth
6.46
2,183.87%
6.070.396.35%
Q1 2021
Q2Q % growth
2.84
911.43%
2.430.4116.66%
Q4 2020
Q2Q % growth
-0.69
-86.49%
-0.35-0.34-95.61%
Q3 2020
Q2Q % growth
-0.59
-59.46%
-0.43-0.16-35.84%
Q2 2020
Q2Q % growth
-0.31
24.39%
-0.360.0513.37%
Q1 2020
Q2Q % growth
-0.35
12.50%
-0.360.012.79%
Q4 2019
Q2Q % growth
-0.37 -0.430.0613.63%
Q3 2019
Q2Q % growth
-0.37 -0.440.0715.31%
Q2 2019
Q2Q % growth
-0.41 -0.450.048.65%
Q1 2019
Q2Q % growth
-0.40 -0.37-0.03-7.65%
MRNA Yearly EPS VS EstimatesMRNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 10 -10 20
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
142M
-41.08%
115.2M26.8M23.26%
Q1 2025
Q2Q % growth
108M
-35.33%
108.32M-320K-0.30%
Q4 2024
Q2Q % growth
966M
-65.64%
961.7M4.3M0.45%
Q3 2024
Q2Q % growth
1.862B
1.69%
1.275B587M46.04%
Q2 2024
Q2Q % growth
241M
-29.94%
134.83M106.17M78.74%
Q1 2024
Q2Q % growth
167M
-91.03%
99.451M67.549M67.92%
Q4 2023
Q2Q % growth
2.811B
-44.71%
2.545B266M10.45%
Q3 2023
Q2Q % growth
1.831B
-45.57%
1.432B399M27.86%
Q2 2023
Q2Q % growth
344M
-92.76%
326.03M17.97M5.51%
Q1 2023
Q2Q % growth
1.862B
-69.30%
1.202B660M54.91%
Q4 2022
Q2Q % growth
5.084B
-29.50%
5.118B-34M-0.66%
Q3 2022
Q2Q % growth
3.364B
-32.30%
3.597B-233M-6.48%
Q2 2022
Q2Q % growth
4.749B
9.07%
4.147B602M14.52%
Q1 2022
Q2Q % growth
6.066B
213.16%
4.709B1.357B28.82%
Q4 2021
Q2Q % growth
7.211B
1,163.54%
6.928B283M4.08%
Q3 2021
Q2Q % growth
4.969B
3,046.93%
6.331B-1.362B-21.51%
Q2 2021
Q2Q % growth
4.354B
6,457.23%
4.292B62M1.44%
Q1 2021
Q2Q % growth
1.937B
22,959.52%
2.078B-141M-6.79%
Q4 2020
Q2Q % growth
570.7M
3,947.52%
285M285.7M100.25%
Q3 2020
Q2Q % growth
157.9M
828.82%
79.063M78.837M99.71%
Q2 2020
Q2Q % growth
66.4M
406.87%
27.977M38.423M137.34%
Q1 2020
Q2Q % growth
8.4M
-47.50%
17.432M-9.032M-51.81%
Q4 2019
Q2Q % growth
14.1M 17.721M-3.621M-20.43%
Q3 2019
Q2Q % growth
17M 18.725M-1.725M-9.21%
Q2 2019
Q2Q % growth
13.1M 19.176M-6.076M-31.69%
Q1 2019
Q2Q % growth
16M 32.742M-16.742M-51.13%
MRNA Yearly Revenue VS EstimatesMRNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-7.24% -16.28% 0% 0.23%
Revenue-17.08% -17.42% -0.61% -4.33%